-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Benzinga·06/29/2026 10:35:10
Listen to the news
Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $537 to $575.